免费文献传递   相关文献

Development of enzymatic synthesis of chiral intermediates for HMG-CoA reductase inhibitors

酶法制备羟甲基戊二酰CoA还原酶抑制剂手性中间体的研究进展



全 文 :!8
"!

#
2010
$

%
>
 
y
 
Œ
 
É
 
ž
 
Ÿ
ChineseJournalofBioprocessEngineering
Vol.8No.1
Jan.2010
doi:10.3969/j.issn.1672-3678.2010.01.014
OPQI
:2009-08-25
KCR!

—èêìíÝäàáâã
(2006C11049)
ST.U

ñ
 
ò
(1960—),
ñ
,^
‹óôô

!"

45ùú

HäåOq£

/-ɟ
,Email:hzwangzhao@163.com
ÜpžFGKŒZH
CoA
IãÜJžû
K€dæÞ_#$¢£
i
 
Þ

ßàà

Ÿáâ

ãäÃ

åEU/01
 
675æçU^1H

èé
310014)
7
 
`

³´¬Þõ
CoA(HMGCoA)
¶HBMN¯œØ7ú·;

¸¹™‚Jº»¡ûB[Ng
HMGCoA

HBMN¯¼°òË8§—˜å½

ïJྶW­û¿…8ÀÇ

hÑÈÁ™B[Ng
HMGCoA
¶HBM
N¯¼°òË8§Ö¢yü­—˜ñ

àíÖÃèÄÅå晽Æ

abc

JྶW
;HMGCoA;
MN¯

¶HB

ÀÇ
defgh
:Q819    
6ijBk
:A    
6l;h
:1672-3678(2010)01-0072-06
Developmentofenzymaticsynthesisofchiralintermediatesfor
HMGCoAreductaseinhibitors
WANGZhao,ZHAORanran,YINGXiangxian,GUOYueping
(ColegeofBiologicalandEnvironmentalEngineering,ZhejiangUniversityofTechnology,Hangzhou310014,China)
Abstract:Inhibitorsof3hydroxy3methylglutarylcoenzymeA(HMGCoA)reductasewereusedashy
polipidemicdrugs.TheprogressforenzymaticsynthesisofchiralintermediatesforHMGCoAreductase
inhibitorswasreviewed,particularlyintheperspectivesofasymmetricsynthesisandracematesresolu
tion.Theapplicationprospectiveoftheintermediatesinindustrywasalsodiscussed.
Keywords:asymmetricsynthesis;HMGCoA;inhibitors;reductase;resolution
  
éú‘’Þ\2žŸ=

Í·ÏÐÑ
CoA
(HMGCoA)
Ò«Hj Y
HMGCoA
>’ÎÍÏ
W

Óg
HMGCoA
Ò«H3Ik

mVÞ\2‘
’

de
,HMGCoA
Ò«HÓgÔCDRB@3B
£

Ô2E

-õÅ

R@¬

X%$&TEÐÎ
3¬yÅÑ

Ù§—ö-õ

÷ö-õ

ö-õ3
Î$Ììן~c¬yÎ$ÌH
20
Y
[1-2]。
$%
ôÅå꜄3Ÿý

-õÅR@¬3Âúq£ã
4ˆ¸

F-õŬy«C¬Þ1Ñí3xGH

ÙÚñŬy345>0 6N-Ù.§og
¬¦[3€UÆ

ÞåÃÛQR>0ÉÊÐÑX
=ÖÄ3‘’ØïF¸ùr345

Hfgh
HMGCoA
Ò«HÓgÔ=ÖÄCDE¥ÄBæk

 YE£

&q{|—ª:sŒ

wYޑ’f=
DsO



HBE YÔÍ=&Â:£

SZ
ëžá“‡dɟ

Hɟùr3äåÕîÍ=³
EH30?

Ik

BækªÁ]k

{,ìEH3
É[Yq£p]F‡î

de

45Hfgh
HMGCoA
Ò«HÓgÔÕk=ÖÄCDìvÞ

HMGCoA
Ò«HÓgÔ=ÖÄuvD
(S)

Æ

͇LW8
、(3S,5R)
Ð͇
6 (
ø

=W18
、(R) 6
Æ

͇

ù‡úL‡8

(R) 4
û‡

͇LW18:

IfWãHÙ
.§Hfgh
HMGCoA
Ò«HÓgÔ=ÖÄ34
5×Ø×npÄ

ð؂RÉ[H。
1 
žF
HMG CoA
IãÜJžûK
€dæÞ_Üáop
  
Hfgh
HMGCoA
Ò«HÓgÔ=ÖÄ3ù
fÍ¿EãQ2‘’fª/¿f

ãQ2‘’f
X£H YgÕkAyzYEÕk0y

Ynµr
E
100%。
/¿fXBæk5 Y§&¼Ä=3

]QEÄ&qìSq*Õk0y

XghÕkY‘
y€q£3ùf

+Rgh£rãE

Ynµr
ß
50%。
1.1 
‹ÂL‘@p
íy¿
HMGCoA
Ò«HÓgÔ=ÖÄXÌã
Q2‘’fgh3

45JE’ü

{t&qí¸
:£ÌYÒ«H1 Y

èDî?K¨q£Fڑ
H=3âFHª<2H=3ò<2H
[3-6]。
ÌYÒ«HOR¤U3¯>yÍ YHÕk
3AyK

“â

ù‡“ø ø&VÒ«

Í#Û>
’Õk=ÖÄ

+Xe Y&qžŸ=ôvåH
3¾Ò

j£åHí¸X
NAD(H)
“
NADP(H)[7]。
dE#ۋŒåH3’I¤YE

j=s,ÞÂ4
5¢£‡dɟÕî1gáÌYÒ«HªåH3
‹ )123{s;<

=9Y&qĽ
[8-9]。
âFHjBæk5 Y
Aldol
F‘&q

ÛÍ
£|ghÕk=ÖÄ
[10],
+Ì|âFH Y3&q
XÍ=3

&qžŸ=ôvëg>0ÉÊ{|:&
qúD¢|0y>’3ùú×n

±8
HMGCoA
Ò«HÓgÔ=ÖÄ3Õk‘’=3q£ðã¸

ò<2HÍ Y§&¼òY‘yzY>’C
DJE
e.e.
É3lW
[11],
Íq£|
HMGCoA
Ò«
HÓgÔòÅ=ÖÄ3Õk‘’=

{]ùf>0
’In

¿‘|É[Y>0
[12]。
1.1.1 
ÌYÒ«H
Ì|ù‡Ay3€€8

ÌYÒ«H=3ù
‡Ò«H8ãQ2Ò«=q£J¸
。HMGCoA
Ò
«HÓgÔÕk=ÖÄó¸ìXÌù‡AyBæ
kÒ«q*3
。4
Æ

ù‡LW8
、6
ø̇
3,5
Ðù‡=W18
、6
Æ
3,5
Ðù‡=WúL
‡8Í8ù‡Ò«H3 YÁgh¤q3
HMG
CoA
Ò«HÓgÔ=ÖÄ

  1)
=

Æ

ù‡LW8EAy
(S) 4
Æ

͇LW8ëžaýu8F‘
&qˆÜøý

Tõ‘’
HMGCoA
Ò«HÓgÔ
3ÕkóýÐ͇lW
[13]。
Ì|

Æ

1Ñ1
W18
(COBE)
H|‘’ZJçnI

=REAy
×n>y Y3ãQ2Ò«&q`´Õk

Æ

͇LW18
(CHBE)
XgÀ67D£3ghj
k

%$1

£H YÒ«
COBE
ghÕk3
CH
BE
K¨J¸

Patel
:
[3]
£
GeotrichumcandidumSC5469
ú
”•›

Æ

1Ñ1WÎ8Ò«q*
(S)4
Æ

͇LWÎ8
((S) CHBM)。
8Ayû?
 ˜E
10g/L
3@AÁ
,(S) CHBM
3qrX
95%,e.e.
É
96%。
ú”•›6žÐ¡Y
(55℃、
30min)
œq£| YÒ«&q
,(S) CHBM
3
e.e.
ɳE¹
98%。
-n×st
G.candidumSC5469
=3ù‡Ò«H³Èð=
EupergitC
E­Ä×n]Yœ£| Y&q
,(S) CHBM
3qrE
90%,
e.e.
É
98%。
{XãH=

Æ

1Ñ1WÎ8
gh
(S) CHBM
TE’i3C$

l¸45¢£‡dɟäå1Ÿ¢ú 
Yij

³EÕk
CHBE
3gh<È
。Davis
:
[14]
¹
Candidamagnoliae
3ù‡Ò«H‡d
、Bacilus
subtilis
3•–péêH‡d
、Candidaboidini

WéêH‡d¿Ña~*íþN
E.coliBL21
=

ëž/-`q=o‡d¤q3H

8
pH7.0
3{

,COBE
8ù‡Ò«H

•–péêH
、NADP+
Ľ=&q
40h,
q*
(S) CHBE。(S) CHBE
£
1W18Å´



ž©ð Fœ

ȘE
97%
M
N

Ì|H3¿ÀžŸÿX

gh’IE
,Matsuy
ama
:
[9]

Pichiafinlandica
3ù‡Ò«H‡dª
Mycobacetrium
ÎWéêH‡d8íþN‹ )

ð£ñú Y
COBE
Bæk3Ò«&q

8Ay
û? ˜
32g/L
3{|Á

q*
(S) CHBE,
qr
E
985%,e.e.
É
99%。
{]ùfèôv=‡dÉ
ŸNBE YÔ

ãôv„ḑ3åHy>Ä
½

&qĽ=E9~

Ì|
COBE
Xs]oš|<3Dxy

ZQú
Dæ€B£

&q£rJn

¢£<

DxšÔ
$¤Ä½jLóï523oÄ;<

ËÕ!:
[15]
8
<

€—ÐÎWÐL8$¤Ä½

¤Äçw
1∶1)
=

£
Na2CO3š›¹<¤ pHëg870,ϏG"/
37 
!

# ñ
 
ò:

HfghÍ·ÏÐÑ
CoA
Ò«HÓgÔÕk=ÖÄ345×Ø
(AureobasidiumpululansCGMCC1244)
ú Y
COBE
ãQ2Ò«

0y
(S) CHBE
qr
948%,
e.e.
É
97.9%,
û? ˜çè)*
582g/L。

À¬›ÄBE&qäûjD£5)×ú Yã
Q2Ò«&q3×n
[16]。
Òsv3DxšÔ¤w

À¬›Äj³EH3¥ÄBækªÁ]k

½#
:
[16]
B£QϏG"/úCD»ï3>y¤ë
k3À¬›Ä



·$Oì%šWß
([bmim]PF6)d¥</[bmim]PF6$¤Ä½,8
30℃、pH6.6、
ùúz™
180r/min
3{|Á

Ϗ
G"/ Y
COBE
ãQ2Ò«q*
(S) CHBE,
&
q3zYr

0y
e.e.
ɪû? ˜¿Ñ)*
956%、985%
ª
471g/L,
랋ŒAy͝0y
û? ˜³E¹
75.1g/L,
‡|À¬›Ä3$¤
&q3q£³EF/¿£r

  2)
=
3,5
Ðù‡

ø̇=W18EAy
(3R,5S) 3,5
Ð͇

ø̇=W18

6žs½Þ&qÍ=‘’-õ¬yÕkóý
5。
Patel
:
[17]
£
AcinetobactercalcoaceticusSC13876
ú
”•› Y
3,5
Ðù‡

ø̇=W18

Ò«q*
2(
ÿ
1),
ñ&q30yqr
85%,e.e.
É
97%。Guo
:
[18]
ì
A.calcoaceticusSC13876

´ÏÒ«H

8åH
NAD+、
•–pª•–péêH
€83{|Á

§

Ò«E

͇

ù‡


ø

=W18

ª

͇

ù‡
6 (
ø

=W
18
4,
ܜ×st

ª

Ò«E
2,
0?E
92%,
e.e.
É
99%。
¤Q|/ú Y

Hf Y×st
³EF0rª
e.e.
É

  3)
=

Æ
3,5
Ðù‡=WúL‡8EAy
(R) 6
Æ

͇

ù‡úL‡8

ÛX
‘’-õ¬yÕkóý

3ìv=ÖÄ
。Wolberg
:
[19]
45F-.ú/úf¥ÄBæk5

Æ
3,5
Ðù‡=WúL‡8

Ò«E
7,
+X¥
ÄBækJ²
(e.e.
É
41%),
+8sY&q{|
œ

0y

3
e.e.
ÉE
94%。
œ1-nì-.ú
=³ÈÏÒ«H
YGL157w
“z/úf&q

0y
e.e.
ÉÔ×st³E¹
99%。
1.1.2 
ڑH
ڑH=3âFHÛÍ£|
HMGCoA
Ò«H
ÓgÔ=ÖÄ3gh=
。2
éÌ¢p

šWâ
FH
(DERA)
 YâF&q

ÿ
2)
Íq*
2,4
Ð
éÌ¢pC>y
10。10
 6’iq£|—ö-õ
ªáö-õ3‘’=
[20]。Greenberg
:
[20]


s
e
1 
ÜpIã
3,5
ZM

N!KOì]~
~

P
3,5
ZMKOìQK~
Fig.1 Diastereoselectiveenzymaticreducitionof
3,5dioxo6(benzyloxy)hexanoicacid
ethylethylesterandtbutyl6chloro3,5
dioxohexanoate
e
2 
ÜpžF
2,4
ZR!S}T•™
Fig.2 Enzymaticpreparationofa2,4dideoxy
hexosederivative
&&q=
,DERA
§ Yâ2F‘&qq*

øŒ
‘y
9。
ܜŒŸ

øâ‡éÄ

×st‘’
10。
dE
DERA
 Y3&qXÍ=&q
,9
3‘’ÛX
Í=3

de

8&qžŸ=0y

¥ZÍ):
H&qø¢×n

ëžaðAyÓgk:sY&
q{|

0y>’r³E¹
30g/(L·h)。
Ì|ú>
N3
DERA
Ayàék²
,Stefan
:
[21]
¢£]ú×
YäåŸä
DERA
3 Ykj

œ‘Eë?ABù
f’i`qFQâÅAyDJïàék3ìÓH

ðZñH3HIwú>N3³EF
10
º

1.1.3 
ò<2H
ò<2H8ÕklW3‘’=CD€q£

ò<2H͝HÕky

͇ÏÐòôQ2Y

ð
q*3
(R) 4
û‡

͇LW
,(R) 4
û‡

͇LWX‘’R\2¬y¥
(Lipitor,
—ö
-õY

3Õk=ÖÄ
[22]。DeSantis
:
[5]
ì‡d(
47
>
 
y
 
Œ
 
É
 
ž
 
Ÿ
  
!

"
 
=`qò<2H‡dð„díþNɟN

ëž
AB

q*jEBæk Y>’

­0y3N]

8Ay67 ˜E
100mmol/L
3&qĽ=

(R)3
͇

û‡LW30rE
98%,e.e.
ÉE
945%。
{]Ý6áâ3ò<2H8Ay ˜ˆŒ
3@AÁ

BækQRn

Ay ˜E
2.25mol/L
Ú
,e.e.
ÉßE
87.8%。DeSantis
:
[22]
×stëž
¿¬>yÞÕî

³EH3AyàékªQEÄB
æk

-n¹{0ò<2H‡dŸäœì.8í
þN= )
,`
q3ò<2Hj8
3mol/L
Ay 
˜Ú×n Y&q

Z0y
e.e.
ÉE
985%。
©Ù
3
Dowpharma
Õkäåqr
[6]
=IJ8ÌÆJÇ
E«C‘’F

͇ÏÐò

×st£ò<2H 
Y

͇ÏÐòôQ2Y&q
,(R) 4
û‡

͇LWqr
100%,e.e.
É
99%,
-n³ëžsY
&q{|

H Y&q3Ayû? ˜³E¹
330g/L,
zYr³EE
100%。
1.2 
0UúÞVfp
Hf/¿=¸:£<2HÅ

<2H/¿§&
¼ÄghÕk=ÖÄ3ùfCDgB9~

ãôv‹
Œåád¬:sŒ

 6€5q£|Õk=ÖÄ3
gh=

<2H=3é)Hª@eHÍ=£|gh
HMGCoA
Ò«HÓgÔÕk=ÖÄ

1.2.1 
é)H
é)Hj§&¼Ay=3)’‡#Bæk
éôS)*Õk/¿3ã3
。Nakagawa
:
[23]
ì^
ƒ=A*Nm
Rhizobiumsp.DS S 51,
jBæk
5 Y§&¼
CHBM
=3
(R) CHBM
<20>
(R) 3
͇ γ L.8,ìSq*E¨ÞȘ3
(S) CHBM。
 Y
CHBM
<23H3¶a‡d
ì
DS S 51
=³´Ï1

ð8
E.coliJM109
=E
£ )

HI³EF
40
º

Ayàék³E¹=H
3

º

é)HãQ2é)fgh
(S) CHBM
Ò
ÌYÒ«f¤w

ãôv‹ŒDE3åH

X

]J
DÉ[q£H\3ÉÊC$

1.2.2 
@eH
@eHj Y8<2

8öX

‰2:&q

Í/
¿§&¼2Å



8ŪÄÅ

 ’Egh¨ÞÈ
Õk¬y3ìväåÕî
[24]。
@eHÍ=
CHBE
3β˜Í‡×nBækÑY,)*/¿ CHBE3ã
3
。Fishman
:
[25]


$tHf&q>0
(R)
“
(S)3
͇LW18 )*q*©Õ
。2
]QEÄ
3YÞȘì)*F
99%,e.e.
É
96%
=o

zYr
E
73%。
!st&q=

Bæk31ÑY
(R) 3
Í
‡LW18


(R) 3
1Ñ̇

ìSÍ¿ÀÏ
ݾÒ&q3
(S) 3
͇LW18

8!Ðt&
q=

!st&q>’3
(R) 3
1Ñ̇A©

ð£1222

q*¨ÞÈ3
(R) 3
͇LW1
8

{

t&q=3 YÔE\]Y3}+}a-
.@eH

ëžHú&q
,e.e.
É
99%、
zYr
73%。
{0žŸ3uvСXãôvšÔ

SZ1ÑYª2
2&qì:£FÙs]H

ÒeÅD
,Hof
:
[26]
8
šÔ—=

=JW1Û8Eч;Ä
,Rhizomucormie
hie
@eH Y
CHBE
ãQ2z8Y

J’i5/¿
F
CHBE,
zYrÍÛ%YnÉ
50%,2
0QEÄ3¨
ÞȘðí|
85%(e.e.)。CHBE
¿¬CD¸0I
+‡#

iF8β˜Í‡o×nÑY§,ÒÍ=Ÿý
Rч3„äSgá/¿

ßM:
[27]
£ºcY3@
eH
Novozym435,
=ÐÌì8BšÔ

¢£‰‡ÎW
õ3¿22Q¸š
NH3,ãQ2‰2/¿ CHBE,
ÍàéAyû? ˜)*F
80g/L。
8
30℃
{|Á
&q
35h,
q*
(R) CHBE,
R¨ÞȘE
99%
(e.e)、
zYrE
577%。
2 
x
 
W
HMGCoA
Ò«HÓgÔ



8ýÃ\M.
3Î$ÌíÙE
200
̇ˆ
[28],
ðàˆÜâO

H
fgh-õ¬y=ÖăO*3HDù‡Ò«H

@eH

é)H

ÑYH

ò<2H

âFH:

±n
8Õk=ÖÄ3gh= áÏ»ï3¥ÄBæk
ª Yj­

8l¸&q=s|Yޑ’f


8453Ќ

£ÌYÒ«HBækÒ«fgh
HMGCoA
Ò«HÓgÔÕk=ÖÄ

Ù.§45q


ìH3>0

‡dɟ

 Y{|:¸ùrì
DÇú345

XãHq£|É[>0wJ’ü3
ùf

R|ŒXåHy>’IJE

>y Y3
§&¼Ä/¿ùf¸]¸¦

R=ò<2H/¿

͇ÏÐò>0’Ión

¿‘|É[Y>0

é
)/¿ÉÊ 68!ögáÉ[Y>0

@eH$
tHf>0

͇LW18 )*É[Y>03


SÙ.@eH‰2/¿ÉÊÛ 6†,b
¢

)*É[Y>0v-

ãH{ùr345ù×
Ýß

M“6i

[1] 


h’K

-õŬyËEB}B£345×Ø
[J].
Â
57 
!

# ñ
 
ò:

HfghÍ·ÏÐÑ
CoA
Ò«HÓgÔÕk=ÖÄ345×Ø
ú.Å
,2008,23(8):604606.
DongXu,LiuSuyun.TheprogressofStatinsinantihypertensive
[J].ClinicalFocus,2008,23(8):604606.
[2] 
Î/

½¥

-õÅR@¬yxG0«
[J].
oU.¬

2005,26(7):313314.
RenJiming,ZhangLi.MarketinganalysisoflipidloweringStatins
[J].ShanghaiPharmac,2005,26(7):313314.
[3] PatelR,McNameeC,BanerjeeA,etal.Stereoselectivereduc
tionofβketoestersbyGeotrichumcandidum[J].EnzymMicrob
Tech,1992,14(9):731738.
[4] GijsenH,WongC.Unprecedentedasymmetricaldolreactionswith
threealdehydesubstratescatalyzedby2deoxyribose5phosphate
aldolase[J].JAmChemSoc,1994,116(18):84228423.
[5] DeSantisG,ZhuZ,GreenbergW,etal.Anenzymelibraryap
proachtobiocatalysis:developmentofnitrilasesforenantioselec
tiveproductionofcarboxylicacidderivatives[J].JAmChemSoc,
2002,124:90249025.
[6] 
`1ÿ

ñò

—ö-õÕk=Öđ’45×Ø
[J].

Ò>yɟ
,2008,25(5):14.
ZhouJinwu,WangZhao.Developmentofsynthesisofchiralinter
mediatesofatovastatin[J].ChemBioeng,2008,25(5):14.
[7] 
2¾M

°Çž

Ùp

>yÒ«&q8Õk¬yãQ2
‘’=3q£
[J].
DxYÞ
,2001,21(6):403412.
WeiZhiliang,LiZuyi,LinGuoqiang.Applicationofbioreduction
totheasymmetricsynthesisofchiraldrugs[J].OrgChem,2001,
21(6):403412.
[8] 
LÝÊ

&ìÓNï‘ãQ2Ò«>0
(R)
“
(S) 4
Æ

͇LW18345
[D].
´H

—èíÞ
,2005.
[9] MatsuyamaA,YamamotoH,KobayashiY,etal.Practicalappli
cationofrecombinantwholecelbiocatalystsforthemanufacturing
ofpharmaceuticalintermediatessuchaschiralalcohols[J].Org
ProcResDev,2002,6(4):558561.
[10]
ï–

âFH Y‘’>&%øýpÅY‘yOR rkj
345
[D].
oU

=ÙÝÞ[oUDxYÞ45j
,2000.
[11]
…Ïc

®3Ù

Bækò<2H8>y Y=3q£
[J].
—
èYÉ
,2009,40(5):1318.
XuSaizhen,ZhengYuguo.Theapplicationofselectivenitrilasein
biocatalysis[J].ZhejiangChemInd,2009,40(5):1318.
[12]SophieB,DavidAC.Nitrilasecatalyseddesymmetrisationof3
hydroxyglutaronitrile:preparationofastatinsidechainintermediate
[J].OrgProcResDev,2006,10(3):661665.
[13]
qfß

(4

…Á5

:
.HMGCoA
Ò«HÓgÔ=ÖÄ
‘’.ÉÊ
[J].
DxYÞ
,2008,28(4):663666.
WangWenjin,ShiWei,XuQinyao,etal.Newprocessforapiv
otalintermediateoftheHMGCoAreductaseinhibitors[J].Org
Chem,2008,28(4):663666.
[14]DavisSC,GrateJH,GrayDR,etal.Enzymaticprocessesfor
theproductionof4substituted3hydroxybutyricacidderivatives:
WO,2004015132[P].20040219.
[15]
ËÕ!

Z¾6

®7

<

DxšÔ$¤Ä½¯>y Yã
Q2Ò«gh
(S) 4
Æ

͇LW18
[J].
EëYÞÉ
ŸÞK
,2007,21(2):310315.
HeJunyao,SunZhihao,ZhengPu.Asymmetricreductionofethyl
4chloro3oxobutanoateinanaqueous/organicsolventbiphasic
systemwithmicroorganism[J].JChemEngChinUniv,2007,21
(2):310315.
[16]
½#

89

Z¾6

:

<

À¬›Ä$¤Ä½=ϏG"
/ Y

Æ 1Ñ1W18ãQ2Ò«‘’
(S) 4
Æ

͇LW18
[J].
 YÞK
,2008,29(6):577582.
ZhangFan,NiYe,SunZhihao,etal.Asymmetricreductionof
ethyl4 chloro 3 oxobutanoatetoethyl(S) 4 chloro 3
hydroxybutanoatecatalyzedbyAureobasidiumpululansinanaque
ous/ionicliquidbiphasesystem[J].ChinJCatal,29(6):
577582.
[17]PatelR,BanerjeeA,McNameeC,etal.Enantioselectivemicro
bialreductionof3,5dioxo6(benzyloxy)hexanoicacid,ethyles
ter[J].EnzymMicrobTech,1993,15(12):10141012.
[18]GuoZ,ChenY,GoswamiA,etal.Synthesisofethylandtbutyl
(3R,5S)dihydroxy6benzyloxyexanoatesviadiastereoanden
antioselectivemicrobialreduction[J].Tetrahedron:Asym,2006,
17(10):15891602.
[19]WolbergM,KaluznaI,MulerM,etal.Regioandenantioselec
tivereductionoftbutyl6chloro3,5dioxohexanoatewithbaker's
yeast[J].Tetrahedron:Asym,2004,15(18):28252828.
[20]GreenbergW,VarvakA,HansonS,etal.Developmentofanef
ficient,scalable,aldolasecatalyzedprocessforenantioselective
synthesisofstatinintermediates[J].ProcNatAcadSciUSA,
2004,101(16):57885793.
[21]StefanJ,MartinS,MichaelW,etal.Directedevolutionofanin
dustrialbiocatalyst:2deoxyDribose5phosphatealdolase[J].
BiotechJ,2006,1(5):537548.
[22]DeSantisG,WongK,FarwelB,etal.Creationofaproductive,
highlyenantioselectivenitrilasethroughgenesitesaturationmuta
genesis(GSSM)[J].JAmChemSoc,2003,125:1147611477.
[23]NakagawaA,SuzukiT,KatoK,etal.Productionof(S)4chlo
ro3hydroxybutyratebymicrobialresolutionusinghydrolasefrom
Rhizobiumsp.DSS51[J].JBiosciBioeng,2008,105(4):
313318.
[24]
½Ù¨

:;<

HfÕk/¿äå45ªq£3T.×Ø
[J].
/íÞÞK

YÞL
,2008,46(5):9971000.
ZhangGuoyan,CaoShugui.Enzymecatalyzedresolutionmethods
andapplication[J].JJinlinUniv:SciEd,2008,46(5):
9971000.
[25]FishmanA,EroshovM,DeeNoorS,etal.Atwostepenzymatic
resolutionprocessforlargescaleproductionof(S)and(R)eth
yl3hydroxybutyrate[J].BiotechBioeng,2001,74(3):
256263.
[26]HofB,AnthonsenT.Lipasecatalyzedresolutionofestersof4
chloro3hydroxybutanoicacid:efectsofthealkoxygroupandsol
ventontheenantiomericratio[J].Tetrahedron:Asym,1999,10
(7):14011412.
[27]
ßM

?ÏÈ

…=

:

Dx¤H Y‰2&q/¿gh
67
>
 
y
 
Œ
 
É
 
ž
 
Ÿ
  
!

"
 
(R)4
Æ

͇LW18
[J].
DxYÞ
,2006,26(10):
13841388.
JinYong,WuJianping,XuGang,etal.Preparationoof(R)
ethyl4chloro3hydroxybutanoatethroughenzymaticammonolysis
inorganicmedia[J].OrgChem,2006,26(10):13841388.
[28]PatelR.Synthesisofchiralpharmaceuticalintermediatesbybioca
talysis[J].CoordinationChemRev,2008,252:
櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒
659701.
34(567
CN101570624 
Or•™"KKX셑mn_žFop
I/ØqïFs]E7˜E>k3>yû‡o)W‘!C3ghùf

RС8|=o)W

BG
EuÄ

ŒŸ¿?3ˆ>ÔªR-áÔ

ã’‘!C

gq3‘!C7˜óE

?®Õ?Í)
5000MPa
=o

?®p˜Í)
80MPa
=o

ː‚kjJï

9º·‚p˜

D|¼

Í)
9kJ/m2
=o

öp˜
Í)
40MPa
=o

4ÚöÜrÍ)
30%
=o

I/ØjÄ3ùfÍííRno)W‘!C3’I

ÙÚ
jq3‘!CCDÍR2k

deCDóï38kJÉ

CN101570774 
=•™ZpžF}•Y9êE_op
I/؃Os]¯>y/-fghž>ƒ„¸3ùf

t,X
:1)
ghž>ƒ„
;2)¸
gh
;3)¯
>y/-
;4)
¿À
;5)
㒒c

I/Ø¢£Â‘H<2

sùr:1)*s]3H2Ÿ˜

Csùr4H
24QR×náâ

=Ÿ»H20yž>¸3¸9

:1BEbc‹ŒÔ“§†ƒ„û3«C

I/Ø
j¢£3¯>yƒ„H

Җyƒ„H

Nyƒ„H¤wCDš2kï

I­E

bskp3Ќ

jLQƒ
„û×nJöŸ˜3<2

CN101575530 
•™"ɼ¬áâžFop
I/ØqïFs]>yû›Y?ORghùf

I/س;3>yû›Y?3ghùf

X@:~
|&q&=Ð2q*>yû›Y?

oÄ&q&.ÍCDkak¬A

jÄkak¬AX¬ÄëŸE}
&q&q*3Ò«k¬A“Bk¬A

Ð23&q—˜E
230~600℃,
jÄÐ23&qÚÖE
0~80min。
8Ð23&q=͌Ÿ YÔ

jÄ YÔEøWß

ñùfgh>yû›Y?)*F
1∶3
3j?0Ÿ0
Ï£r

>yû›Y?3ÐÉÈðE)
3465MJ/kg,
ÙÚJEÁ]

CN101575624 
=•™ÜUú•DL
Þ©ì_op
I/؃O¯>yH&¼>0
DL
J‰W3ùf

ÎÏ=Át,

Œg…†‡

£‰<“
H2SO4Ë/…
†‡
pH
*
8,
¿}Ÿ"ø=

k€8‚ro3¯>y£Û]8ã´s8۟oą†‡=

:£¼z¦§
°

8
30℃、110r/min
Á…†
24h,
‘ðoÄú…†›

ŒŸ*Ayš›=

m2&q—˜
30℃、pH7,
&
qžŸûRÚ£¼¨¬¡?&qĽw¼¨˜

7w¼¨˜E

Ú

¡Q&q

ŒŸIkCé™
30min,
‹
©

£¼z”ªŠ/°s4 Fœ

q
DL
J‰W:gc

I/Ø>0ùf«CHq

>0žŸ9~

{
|—ª

jí_˜Rn
DL
J‰W>0’I

CN101580856 
Z[ƒ³Ë™ÚãnZ•\=•™¬µ_op
I/Øqï=«[;£yE«C/->0¯>y?@3ùf

ñùf«[;£y£·W<2

<2
›62愡Yœgh/-…†‡

 F¹Ò«pû? ˜E
80~120g/L,
ܜœ¹R8”‘y=3 ˜
77 
!

# ñ
 
ò:

HfghÍ·ÏÐÑ
CoA
Ò«HÓgÔÕk=ÖÄ345×Ø